Delivery Order SPE2DB22D2007-SPE2DB25FH8BT

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $94K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Abiraterone Acetate 250 mg tablets (120 count) to the Defense Logistics Agency (DLA). The $1,667.28 firm fixed price delivery order has a completion date of November 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,182.10 firm fixed-price delivery order contract is for the supply of 4,565,950,374 units of abiraterone acetate 250 mg tablets. The contract has an ultimate completion date of September 27, 2024. This delivery order is issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,930.76 firm fixed-price delivery order contract is for the supply of 4564792490 abiraterone acetate 250 mg tablets. The contract has an ultimate completion date of June 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,198.05 firm fixed-price delivery order is for the supply of 4,564,942,425 units of the pharmaceutical drug Abiraterone Acetate 500 mg tablets. The contract has a period of performance through June 20, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,262.07, is for the delivery of abiraterone acetate 500 mg tablets. The contract is a delivery order with a firm fixed price and has an ultimate completion date of December 12, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of Abiraterone Acetate 250 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,546.31, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,804.99 firm-fixed-price delivery order is for 4,567,025,743 units of Abiraterone Acetate 500 mg tablets. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,054.96 Firm Fixed Price Delivery Order contract is for the supply of 120 count bottles of Abiraterone Acetate 250 mg tablets, a medication used in the treatment of prostate cancer. The contract has an ultimate completion date of March 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,828.50 Firm Fixed Price Delivery Order is for the supply of 4566412806 - ABIRATERONE ACETATE 500 MG TAB 60S, with an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,481.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,566,734,838 units of Abiraterone Acetate 500 mg tablets. This is a Firm Fixed Price delivery order with a completion date of December 17, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH8BT
    Delivery Order

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 250 mg tablets. The contract, valued at $94,299.16, has a period of performance through January 8, 2025 and utilizes a firm fixed-price pricing type.

AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award referenced does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:32 AM